Open AccessRetrospective review analysis of COVID-19 patients co-infected with Mycoplasma pneumoniae
Author(s) -
Abhinav Choubey,
Diaeddin Sagar,
Philippa Cawley,
Katherine Miller
Publication year - 2021
Publication title -
lung india
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 25
eISSN - 0974-598X
pISSN - 0970-2113
DOI - 10.4103/lungindia.lungindia_607_20
Subject(s) - medicine , procalcitonin , mycoplasma pneumoniae , coinfection , retrospective cohort study , pneumonia , atypical pneumonia , neutrophilia , immunology , virus , sepsis
Coronavirus disease 2019 (COVID-19) is an extremely infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The outbreak of this virus has resulted in significant morbidity and mortality throughout the world. We have seen an unprecedented spread of this virus, leading to extreme pressure on health-care services. Mycoplasma pneumoniae causes atypical bacterial pneumonia and is known to co-infect patients with viral pneumonias.